Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 January 2019 | Story Xolisa Mnukwa | Photo Anja Aucamp
Prof Francis Petersen speech
“We can create an institution that operates and lives in the times of embracing and celebrating diversity, inclusivity, and academic excellence by ensuring that students own their time at university,” said Prof Francis Petersen.

25 January 2019 marked the official welcoming of the University of the Free State’s (UFS) first-year students, as they moved into their respective residences and were warmly welcomed on the UFS Bloemfontein Campus. This day also marked the start of the registration process for first-year students.

According to first-year Psychology student Keisha Claasen, who moved into her residence earlier on 25 January, her first experience of the UFS was daunting but exciting, as she had never been in a similar environment. According to Given Gwerera, who dropped his son off at the Karee residence earlier the day, “the UFS is an institution with great culture and an overall good academic record.” He further explained that he trusts his son to make full use of the opportunities presented to him, as he has a cool head on his shoulders.

On the evening of 25 January, an eager group of millennials, joined by their parents, took the first sip from their cup of varsity life as they assembled on the Red Square of the Bloemfontein Campus to meet the Rector and Vice-Chancellor, Prof Francis Petersen, members of Rectorate, the deans of all faculties, and the Student Representative Council (SRC) of the UFS.

“2019 will be a year of continued change; the UFS is thrilled about the prospect of bringing about opportunities for adaptation and realignment to the future,” said Prof Francis Petersen.

He further explained that the university prides itself in moulding its students into well-rounded individuals who will develop into globally competitive graduates as required in a diversity of landscapes. Prof Petersen urged first-years to remain open to the technological developments that go with globalisation, because of its permanent effects on society today.

First-years were further advised to take advantage of the rich pool of academic research and knowledge that is characteristic of the university and is piloted by UFS scholars, by engaging with and learning from them.

The inspiring night concluded on a colourful note, as the audience enjoyed an artistic laser show in front of the Main Building. Caption:

“UFS academics conduct research that forces the world to take note,” said Prof Francis Petersen at the official first-year welcoming ceremony on the UFS Bloemfontein Campus.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept